Transdermal absorption of L-dopa from a new system composed of two separate layers of L-dopa and hydrogel in rats

被引:10
|
作者
Iwase, H
Sudo, J [1 ]
Terui, J
Kakuno, K
Watanabe, T
Takayama, K
Nagai, T
机构
[1] Hlth Sci Univ Hokkaido, Fac Pharmaceut Sci, Dept Clin Pharmacol & Toxicol, Ishikari, Hokkaido 0610293, Japan
[2] Hoshi Univ, Dept Pharmaceut, Shinagawa Ku, Tokyo 1428501, Japan
关键词
L-dopa; hydrogel; rat; transdermal absorption;
D O I
10.1081/DDC-100101294
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
To maintain the stability of L-dopa in hydrogel, a new system composed of two separate layers of L-dopa and hydrogel was developed. L-Dopa sheets were made by immersing L-dopa solutio into wipe sheets and by lyophilizing them. Examination for stability of L-dopa in the L-dopa sheet revealed that its stability was maintained for at least 12 weeks, providing the sheet was kept at room temperature in a dark box. In a cutaneous adsorption study of L-dopa in rats, an L-dopa sheet was attached to the shaved abdominal skin. A hydrogel composed of cutaneous adsorption enhancers, water and ethanol, was spread on vinyl tape (hydrogel sheet), and this sheet was placed over the L-dopa sheet. L-Dopa that was administered transdermally effectively penetrated through the skin: The plasma level of L-dopa peaked at 30 min and remained high between 60 and 180 min after the cutaneous application. Our system, composed of two separated layers of L-dopa and hydrogel, enabled the stability of L-dopa to be maintained without losing transdermal absorption of L-dopa.
引用
收藏
页码:755 / 759
页数:5
相关论文
共 50 条
  • [1] Transdermal absorption of L-dopa from hydrogel in rats
    Sudo, J
    Iwase, H
    Terui, J
    Kakuno, K
    Soyama, M
    Takayama, K
    Nagai, T
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 7 (01) : 67 - 71
  • [2] STUDIES ON L-DOPA ABSORPTION
    JAGENBURG, R
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1971, 27 : 68 - +
  • [3] Elevation of plasma levels of L-dopa in transdermal administration of L-dopa-butylester in rats
    Sudo, J
    Iwase, H
    Higashiyama, K
    Kakuno, K
    Miyasaka, F
    Meguro, T
    Takayama, K
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2002, 28 (01) : 59 - 65
  • [4] L-dopa
    Voith, M
    [J]. CHEMICAL & ENGINEERING NEWS, 2005, 83 (25) : 60 - 60
  • [5] L-DOPA
    WILSON, LA
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1972, 2 (01): : 96 - &
  • [6] AMANTADINE VERSUS L-DOPA AND AMANTADINE PLUS L-DOPA
    FIESCHI, C
    NARDINI, M
    CASACCHIA, M
    TEDONE, ME
    REITANO, M
    ROBOTTI, E
    [J]. LANCET, 1970, 2 (7664): : 154 - +
  • [7] VARIABILITY OF L-DOPA ABSORPTION IN MAN
    MEARRICK, PT
    WADE, DN
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1973, 3 (03): : 337 - 337
  • [8] VARIABILITY OF L-DOPA ABSORPTION IN MAN
    WADE, DN
    MEARRICK, PT
    BIRKETT, DJ
    MORRIS, J
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1974, 4 (02): : 138 - 143
  • [9] A NEW SYSTEM FOR L-DOPA DELIVERY TO BRAIN
    BORISON, RL
    DIAMOND, BI
    BAUER, ML
    RAJAN, KS
    [J]. NEUROLOGY, 1980, 30 (04) : 365 - 365
  • [10] Antagonism by L-DOPA cyclohexyl ester against behavioral effects of L-DOPA in rats.
    Matsushita, N
    Misu, Y
    Goshima, Y
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 202P - 202P